Search - tctmd.com

Displaying 701 - 720 of 2954

Sort: Relevancy | Date

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

Presenter: Manel Sabate

September 27, 2019

Presentation TCT 2019

Case Introduction: A Patient Requiring Urgent Noncardiac Surgery After Recent Stent Implantation

Presenter: Giulio Stefanini

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

Presenter: Bernardo Cortese

September 27, 2019

Presentation TCT 2019

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

Presenter: Marianne Brodmann

September 27, 2019

Presentation TCT 2019

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

Presenter: Marianne Brodmann

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

Presentation TCT 2019

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Presenter: Bram Zuckerman

September 27, 2019

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

Presentation TCT 2019

Answers and Questions After AUGUSTUS

Presenter: C. Michael Gibson

September 27, 2019

Presentation TCT 2019

Balancing Efficacy and Safety in Trial Interpretation

Presenter: David Cohen

September 27, 2019

Presentation TCT 2019

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Presenter: Eric Secemsky

September 27, 2019

Presentation TCT 2019

Most Contemporary DES Will Provide Similar Outcomes!

Presenter: Davide Capodanno

September 27, 2019

Presentation TCT 2019

When the Primary Endpoint Is Missed: The CABANA Case Study

Presenter: Bernard Gersh

September 27, 2019

Presentation TCT 2019

Alternatives to Intention to Treat Analysis: Can They Be Trusted?

Presenter: Stuart Pocock

September 27, 2019

Presentation TCT 2019

Complex and High-Bleeding Risk Patients: Why We Still Need DES Innovation

Presenter: Robert Yeh

September 27, 2019

Presentation TCT 2019

Fundamentals of Stent Design: The BP-DES Sweet Spot

Presenter: Aloke Finn

September 27, 2019

Presentation TCT 2019

Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking Science

Presenter: Ajay Kirtane

September 27, 2019

Advertisement

Defining High Bleeding Risk: HBR ARC

MAGSTEMI: A Randomized Trial of a Magnesium-Based Sirolimus-Eluting Resorbable Scaffold vs. Metallic DES in Patients With STEMI

Case Introduction: A Patient Requiring Urgent Noncardiac Surgery After Recent Stent Implantation

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

PICCOLETO II: 6-Month Clinical and Angiographic Findings From a Randomized Trial of Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Small Vessel Coronary Artery Disease

TOBA III: 1-Year Outcomes From a Single-Arm Study of Focal Dissection Repair After Drug-Coated Balloon Angioplasty of Superficial Femoral And Proximal Popliteal Arteries

LUTONIX BTK Diabetes: Outcomes From a Randomized Trial of a Drug-Coated Balloon vs. Standard Angioplasty in Diabetic Patients With Below-the-Knee Disease

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Devices for Heart Failure: FDA Perspectives on Trial Designs and Endpoints

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Answers and Questions After AUGUSTUS

Balancing Efficacy and Safety in Trial Interpretation

Drug-Coated Balloons in the Periphery: Red Alert or Red Herring?

Most Contemporary DES Will Provide Similar Outcomes!

When the Primary Endpoint Is Missed: The CABANA Case Study

Alternatives to Intention to Treat Analysis: Can They Be Trusted?

Complex and High-Bleeding Risk Patients: Why We Still Need DES Innovation

Fundamentals of Stent Design: The BP-DES Sweet Spot

Short and Optimal DAPT: Lessons From the EVOLVE SHORT-DAPT Late Breaking Science

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content